MOESM2 of Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Authors :: Jacot, William
Cottu, Paul
Berger, Frederique
Dubot, Coraline
Venat-Bouvet, Laurence
Lortholary, Alain
Bourgeois, Hugues
Bollet, Marc
Servent, Veronique
Luporsi, Elisabeth
Espié, Marc
Guiu, Severine
D’Hondt, Veronique
Dieras, Veronique
Marie-Paule Sablin
Brain, Etienne
Souhir Neffati
Jean-Yves Pierga
Francois-Clement Bidard
Publication Year :: 2019
Publisher :: figshare, 2019.
Abstract: Additional file 2. Table S1. Univariate and multivariate analyses for PFS and OS (screened population). For multivariate analyses, only significant results are shown. MBC: metastatic breast cancer.

Full Text Access

Tools